KR101923781B1 - The preventing prostate cancer composition containing high platycodin aged Doraji extract methods - Google Patents

The preventing prostate cancer composition containing high platycodin aged Doraji extract methods Download PDF

Info

Publication number
KR101923781B1
KR101923781B1 KR1020160176600A KR20160176600A KR101923781B1 KR 101923781 B1 KR101923781 B1 KR 101923781B1 KR 1020160176600 A KR1020160176600 A KR 1020160176600A KR 20160176600 A KR20160176600 A KR 20160176600A KR 101923781 B1 KR101923781 B1 KR 101923781B1
Authority
KR
South Korea
Prior art keywords
extract
prostate cancer
aged
platycodin
hours
Prior art date
Application number
KR1020160176600A
Other languages
Korean (ko)
Other versions
KR20180073109A (en
Inventor
이은주
최금부
김태석
여익현
이상윤
남승우
Original Assignee
주식회사 풀무원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 풀무원 filed Critical 주식회사 풀무원
Priority to KR1020160176600A priority Critical patent/KR101923781B1/en
Publication of KR20180073109A publication Critical patent/KR20180073109A/en
Application granted granted Critical
Publication of KR101923781B1 publication Critical patent/KR101923781B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/10Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/113Acidophilus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/169Plantarum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/41Pediococcus
    • A23V2400/413Acidilactici
    • A23Y2220/03
    • A23Y2220/67
    • A23Y2280/15

Abstract

본 발명은 전립선암 예방 효과에 우수한 도라지에 함유된 사포닌의 일종인 플라티코딘을 고순도로 함유하는 숙성흑도라지 추출물을 제조하는 방법에 관한 것으로서, 보다 상세하게는 도라지를 증자 건조한 후 주정으로 추출한 추출물에 혼합유산균 3종 배양후 배양액에 1종 효모를 배양시킨 후, 상기 추출물을 농축하여 이온교환수지 칼럼을 통하여 고순도의 플라티코딘을 함유하는 숙성흑도라지 추출물을 함유하는 전립선암 예방용 건강식품에 관한 것이다.
본 발명에 의하면, 플라티코딘 A, D를 고순도로 함유하는 숙성흑도라지 추출물은 전립선암 세포의 성장을 억제하고 세포사멸을 유도하는데 우수한 효과가 있어 전립선암 치료 및 예방에 효과적으로 사용할 수 있다.
The present invention relates to a method for producing an aged blackflower extract containing platycodin, which is a kind of saponin contained in platycodon, which is excellent in the prevention of prostate cancer, and more specifically, , The yeast is cultured in a culture medium after three kinds of mixed lactic acid bacteria are cultured. Then, the extract is concentrated to prepare a health food for prevention of prostate cancer containing an aged black platycodone extract containing high purity platycodine through an ion exchange resin column .
According to the present invention, the aged Blackberry extract having high purity of platycodin A and D can be effectively used for the treatment and prevention of prostate cancer because it has an excellent effect of inhibiting the growth of prostate cancer cells and inducing apoptosis.

Description

전립선암 예방 효과에 우수한 고순도 플라티코딘 함유 숙성흑도라지 추출물 및 이의 제조방법{The preventing prostate cancer composition containing high platycodin aged Doraji extract methods} [0001] The present invention relates to a method for preparing a platycodin-containing platycodin,

본 발명은 전립선암 예방 효과에 우수한 도라지에 함유된 사포닌의 일종인 플라티코딘을 고순도로 함유하는 숙성흑도라지 추출물을 제조하는 방법에 관한 것이다.
The present invention relates to a method for producing an aged blackberry extract having high purity of platycodin, which is a kind of saponin contained in platycodon, which is excellent in the effect of preventing prostate cancer.

최근 식품산업은 식품소재가공기술을 기반으로 다양한 BT기술이 융합되면서 빠르게 변화하고 있으며, 기존의 웰빙(well-being)개념보다 한걸음 더 나아가 지속적으로 건강을 유지할 수 있는 환경 친화적인 LOHAS 트랜드로 가고 있다. 또한 삶의 질 향상과 의료기술의 발전으로 인하여 수명이 연장됨에 따라 암, 심장질환, 당뇨, 관절염 등과 같은 만성 또는 난치성 질병이 증가하고 있어, 식품산업에서도 다양한 질병에 대한 예방과 개선을 위한 고부가가치 식품소재와 기능성 식품이 많은 관심을 받고 있는 실정이다.
Recently, the food industry is rapidly changing with the fusion of various BT technologies based on the food material processing technology, and going to the environment-friendly LOHAS trend that can maintain the health more than the existing well-being concept one by one . In addition, chronic or intractable diseases such as cancer, heart disease, diabetes and arthritis are increasing due to the improvement of the quality of life and the development of medical technology, so that the food industry has high added value for prevention and improvement of various diseases Food materials and functional foods are attracting much attention.

지난 수 십년간 암은 전 세계적으로 사망률이 높은 질병으로 지속적인 의학발전에도 불구하고 계속 증가하고 있는 추세이며, 이중 전립선암은 저 세계적으로 가장 흔하게 발생되는 비뇨기과 종양 중 하나로써 남성에게는 암사망률에서 2위로 나타났다. 이는 국내에서도 전립선암 환자가 20년 동안 21배 급증한 것으로 나타나 현대인에게 가장 흔하게 발병하는 질병중 하나로 인식되고 있다. 현재 시판되고 있는 전립선암 치료제의 대부분은 합성 의약품들이 이용되고 있으며, 이들 치료제는 장기 투여시 내성이 생기는 등 다양한 부작용이 나타남으로써 최근의 연구 방향은 안전성이 보장된 식물, 미생물 유래의 천연자원을 이용하여 부작용을 감소시키면서 암세포에만 특이적으로 작용하여 정상세포에 영향을 주지 않는 새로운 천연물 유래 치료제 개발이 요구되는 실정이다.
Over the past decade, cancer has been the leading cause of mortality worldwide, and continues to grow despite continued medical advances. Prostate cancer is one of the most commonly occurring urological tumors worldwide, appear. In Korea, the number of prostate cancer patients has increased by 21 times in 20 years, which is recognized as one of the most common diseases among modern people. Most of the currently marketed prostate cancer medicines are synthetic medicines. These medicines have various side effects such as tolerance for long-term administration. Therefore, recent research directions are to use natural resources derived from plants and microorganisms which are guaranteed to be safe It is required to develop a new therapeutic agent derived from natural products which does not affect normal cells by specifically acting only on cancer cells while reducing side effects.

항암 치료제는 암세포 사멸의 apotosis를 유도하여 암의 발생 및 진행을 억제하는데, 전립선은 대부분 세포자기사멸에 관여하는 신호전달의 결함으로 인하여 세포증식 및 세포사멸의 불균형을 야기시켜 종양의 발달 및 전이를 야기시키게 된다. 일반적인 세포자기사멸 신호전달 경로는 카스파제(caspase) 효소 활성에 의한 것으로, caspase는 여러 가지 세포자기사멸 시그널에 의해서 활성화된다. 그 중 caspase-3는 세포사멸의 실행자로서 상위의 caspase-9에 의해 활성화되고 이후에 DNA 복구 효소에 해당하는 폴리(ADP-리보스) 중합효소(PARP)를 비활성화시켜 손상되 DNA 복구 경로를 차단함으로써 세포사멸을 유도한다. 세포자기사멸 관련 신호전달경로에 있어서 caspase-3는 마지막 실행자로써 핵심적인 역할을 담당함에 따라 caspase-3를 주요 타겟 단백질로 전립선암 세포사멸에 효과적인 소재 발굴이 이루어지고 있다.
The cancer treatment induces apoptosis of cancer cells and inhibits the development and progression of cancer. The prostate gland causes defects in signal transduction involved in cell apoptosis, leading to unbalance of cell proliferation and apoptosis, leading to tumor development and metastasis . The general pathway of apoptosis is mediated by caspase enzyme activity, and caspases are activated by various cell death signals. Caspase-3 is activated by caspase-9 as an activator of apoptosis, and then it is damaged by inactivating poly (ADP-ribose) polymerase (PARP) Induce apoptosis. As caspase-3 plays a key role as a final executor in cell apoptosis-related signal transduction pathways, caspase-3 is a major target protein and effective material for prostate cancer cell death has been discovered.

본 발명은 세포독성이 없는 천연물들의 생리활성을 연구하던 중 전통적인 생약재 및 식품으로 활용하고 있는 도라지로부터 다양한 면역학적 효과인 폐암억제, 항균, 항염, 및 알코올성간질환의 억제 등 도라지 추출물을 포함하는 다양한 한방제제가 개시되어 있는 것을 확인할 수 있으며, 특허 제 0830236에는 도라지 추출물을 함유하는 전립선암 예방 및 치료용 조성물이 개시되어 있고, 공개특허 제 2012-0117197에는 면역활성 및 항암활성 효과를 갖는 조성물이 개시되어 있으나, 상기 공지된 기술의 경우 도라지 추출물 또는 분획의 경우 통상의 천연물로부터 유효성분을 추출하기 위하여 순차적으로 극성이 다른 용매를 추출용매로 사용하고 있는 등 큰 차이가 없다.
While studying the physiological activity of natural products without cytotoxicity, the present invention has been applied to a variety of medicines including bradykinin extracts such as inhibition of lung cancer, antibacterial, anti-inflammatory and alcoholic liver diseases, A composition for prevention and treatment of prostate cancer is disclosed. Patent Publication No. 0830236 discloses a composition for prevention and treatment of prostate cancer, which contains a bellflower extract. In the patent publication No. 2012-0117197, a composition having an immunological activity and an anticancer activity effect is disclosed However, in the case of the above-described known techniques, in the case of the platycodon grandiflorum extract or fraction, there is no significant difference in that a solvent having a different polarity is sequentially used as an extraction solvent in order to extract an active ingredient from a natural product.

따라서 본 발명은 5년근 이상 도라지(약도라지)를 수확하고 이를 일정한 온도에서 증숙과 건조의 과정을 거쳐 생성된 흑도라지로부터 플라티코딘이 고순도로 함유된 숙성흑도라지 추출물의 전립선암 세포주 LNCap을 농도 의존적으로 자기사멸시키며, 또한 세포자기사멸의 핵심 실행자인 caspase-3 활성을 높이는 작용을 동시에 나타내고 있으므로, 전립선암 세포주 사멸에 유용하게 활용될 수 있음을 밝힘으로써 본 발명을 완성하게 되었다.
Accordingly, the present invention relates to a method for producing a prostate cancer cell line LNCap, which is obtained by harvesting platycodon (Rhodophyta) of 5 years or more over a period of 5 years or more, and platycodin- Dependent activation of caspase-3, and it also shows the action of enhancing caspase-3 activity, which is a core executor of cell apoptosis. Thus, the present invention has been completed.

본 발명은 부작용이 없는 천연물 유래의 전립선암 세포자기사멸에 효과적인 소재를 개발하기 위한 연구결과, 5년근 이상 도라지(약도라지)를 수확하고 이를 일정한 온도에서 증숙과 건조의 과정을 거쳐 생성된 흑도라지로부터 플라티코딘이 고순도로 함유된 숙성흑도라지 추출물이 전립선암 세포주의 자기세포사멸을 유도하고 또한 세포자기사멸의 핵심 실행자인 caspase-3활성을 높이는데 우수한 효과를 규명함으로써 본 발명을 완성하게 되었다.
The present invention has been made to develop a material effective for the self-destruction of prostate cancer cells derived from natural products without side effects, and as a result, it has been found that, when a platycodon (platycodon) of 5 years or more is harvested and cultured at a constant temperature, , The present inventors have completed the present invention by confirming the excellent effect of aged blackberry extract having high purity of platycodin in inducing magnetic cell apoptosis of prostate cancer cell line and enhancing caspase-3 activity as a key executor of cell apoptosis .

따라서 본 발명의 목적은 전립선암 예방 효과에 우수한 고순도 플라티코딘 함유 숙성흑도라지 추출물 제조방법을 제공하는데 있다.Accordingly, an object of the present invention is to provide a method for producing a high-purity platycodin-containing aged blackrox extract which is excellent in preventing prostate cancer.

상기의 목적을 달성하기 위하여, 본 발명은 전립선암 예방 효과에 우수한 고순도 플라티코딘을 함유하는 숙성흑도라지 추출물 제조 방법을 제공하는 것이다.
In order to accomplish the above object, the present invention provides a method for preparing an aged blackrox extract having high purity platycodin which is excellent in preventing prostate cancer.

이하, 본 발명을 상세히 설명한다.
Hereinafter, the present invention will be described in detail.

도라지(Platycodon grandiflorum)는 초롱꽃과(Campanulaceae)에 속하는 다년생 초본으로서, 뿌리가 전통적인 생약재 또는 식품으로 활용되고 있으며, 거담작용, 진해작용, 해열, 진통 등의 다양한 약리작용이 있는 것으로 알려져 있다. 이외에 알려진 약리효과로는 항염증, 혈압강하작용, 용혈작용, 중추억제작용 등의 효능이 있는 것으로 보고되어 있다.
Platycodon grandiflorum is a perennial herb that belongs to Campanulaceae. Its roots are used as traditional herbal medicines or foods. It is known to have various pharmacological actions such as gadolin, vinegar, fever and analgesia. Other known pharmacological effects include anti-inflammatory, hypotensive, hemolytic, and central inhibitory effects.

특히 도라지에의 면역학적 효과에 대한 연구보고에 의하며, 트리테르펜계 사포닌 등의 활성물질들이 함유되어 있는 것으로 보고되어져 있으며, 보고된 성분으로는 플라티코디제닌(platycodigenin)의 배당체인 플라티코딘(platycodin) A, C, D 등 10여종의 트리테르펜 사포닌이 미량으로 함유되어 있는 것으로 보고되어져 있다.
In particular, it has been reported that active substances such as saponin such as triterpene are contained according to a study report on the immunological effect on the bellflower, and reported ingredients include platycodigen (glycyrrhizin), platycodigenin Platycodin) A, C, D, and 10 kinds of triterpene saponins have been reported to contain trace amounts.

이에 본 발명자는 약리활성이 높은 5년근 이상의 가을산 도라지를 수확하고, 도라지에 함유된 다양한 약리 활성을 나타내는 플라티코딘 성분을 고함량으로 제조하기 위하여 (a) 도라지를 일정한 온도에서 증숙과 건조하는 단계; (b) 숙성흑도라지를 주정 또는 이와 물의 혼합용매로 이루어진 군으로부터 선택된 어느 하나의 용매로 추출하는 단계; (C) 추출액에 3종 김치 유래 3종 혼합 유산균인 락토바실루스 플란타룸(Lactobacillus plantarum), 락토바실루스 에시도필러스(Lactobacillus acidophilus), 페디오코코스 에시디락틱(Pediococcus acidilactici)을 중량1~10%로 접종하여 35~37℃에서 48시간 배양후 막걸리에서 분리된 사카로미세스 세레비시아(Saccharomyces cerevisiae) 효모를 접종하여 30~35℃에서 48시간 2차 배양시킨 단계; (d) 상기 배양된 추출물을 농축하는 단계; (e) 상기 농축물에서 이온교환수지를 채운 칼럼에 흡착시킨 후, 칼럼에 흡착되어 있는 물질을 주정으로 용리하여 정제하는 단계를 포함하여 제조하였다.Accordingly, the present inventors have succeeded in obtaining a platycodin ingredient having high pharmacological activity over a 5-year-old muscle or more and exhibiting various pharmacological activities contained in the platycodon, (a) ; (b) extracting the aged blackflower with any one solvent selected from the group consisting of a mixture of water and water; (C) Lactobacillus plantarum , Lactobacillus acidophilus , and Pediococcus acidilactici , which are three kinds of three kinds of kimchi-derived lactic acid bacteria, %, Cultured at 35 to 37 ° C for 48 hours, inoculated with Saccharomyces cerevisiae yeast isolated from makgeolli, and cultured at 30 to 35 ° C for 48 hours. (d) concentrating the cultured extract; (e) adsorbing the concentrate on a column filled with an ion exchange resin, and then purifying the material adsorbed on the column by eluting with a solvent.

본 발명의 전립선암 예방 및 치료용 식품 조성물은 세포자기사멸의 주요 실행자인 caspase-3 활성 증가를 통한 효과적인 세포자기사멸을 유도하는 효과를 나타낸다. 본 발명의 식품 조성물은 그 효과를 증진시키기 위해 식품학적으로 허용되는 다른 생약제 또는 그 외 추출물을 추가로 함유할 수 있다. 이 경우 상기 방법으로 추출한 생약재 추출물을 첨가하거나, 다른 생약재를 혼합한 후 상기 방법으로 추출하여 식품에 함유시킬 수 있다.
The food composition for preventing and treating prostate cancer of the present invention has an effect of inducing an effective cell death by increasing caspase-3 activity which is a main executor of cell death. The food composition of the present invention may further contain another herb medicine or other extract which is pharmacologically acceptable to enhance its effect. In this case, the herbal medicine extract extracted by the above method may be added, or the other herbal medicines may be mixed and then extracted by the above-mentioned method to be contained in the food.

상기한 바와 같이 도라지에서 고순도의 플라티코딘을 함유한 추출물을 제조하는 방법 및 상기 방법에 의하여 제조된 고순도의 플라티코딘 함유 숙성흑도라지 추출물을 제공한다. 본 발명의 추출물은 고순도의 플라티코딘이 함유되어 있어 전립선암 에방 효과에 우수하다.
As described above, the present invention provides a method for producing an extract containing platycodin of high purity in a bellflower and a high-purity platycodine-containing maturation black rot flower extract prepared by the method. The extract of the present invention contains platycodin of high purity and is excellent in the effect of prostate cancer.

도 1은 본 발명에 따른 고순도 플라티코틴이 함유된 숙성흑도라지 추출물의 제조방법을 나타낸 모식도이다.
도 2은 본 발명에 의해 제조된 숙성흑도라지 추출물과 이온교환수지를 통해 정제된 고순도의 플라티코딘 함유 숙성흑도라지 추출물의 LC/MS 분석 결과이다.
도 3은 본 발명에 따른 숙성흑도라지 추출물의 LNCap 세포주의 세포사멸에 미치는 농도 의존적 영향 평가 결과이다.
도 4은 본 발명에 따른 숙성흑도라지 추출물의 LNCap 세포주의 세포사멸에 미치는 시간 의존적 영향평가 결과이다.
도 5는 본 발명에 따른 숙성흑도라지 추출물의 LNCap 세포주의 caspase-3 발현에 미치는 영향 평가 결과이다.
FIG. 1 is a schematic view showing a process for producing an aged blackrox extract containing high-purity platocyte according to the present invention.
FIG. 2 is a result of LC / MS analysis of a high-purity platycodine-containing maturing black lotion extract purified through an aged blackrod berry extract prepared by the present invention and an ion exchange resin.
FIG. 3 shows the results of the concentration-dependent effect evaluation of the LNCap cell line on the apoptosis of the aged Blackflower extract according to the present invention.
FIG. 4 is a time-dependent effect evaluation result on the cell death of the LNCap cell line of the aged Blackflower extract according to the present invention.
FIG. 5 shows the results of the evaluation of the effect on the caspase-3 expression of the LNCap cell line of the aged Blackflower extract according to the present invention.

이하 본 발명을 실시예에 의해 자세히 설명한다. Hereinafter, the present invention will be described in detail with reference to Examples.

단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.
However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.

<< 실시예Example 1> 고순도  1> High purity 플라티코딘Platycodine 숙성흑도라지Aging Black Bellflower 추출물을 함유하는 조성물의 제조 Preparation of compositions containing extracts

본 발명에 사용한 도라지는 경북 영주에서 5년근 이상 재배된 (약)도라지를 수확한후 세척된 도라지를 90~95℃에서 2시간 증자한후 50~60℃에서 55~70시간 동안 건조한후, 건조된 도라지를 다시 90~95℃에서 2시간 증자한후 50~65℃에서 55~70시간 건조하는 것을 반복하여 수분함량 8~13%의 숙성흑도라지로 제조한후 500중량%의 정제수를 투입하여 교반하면서 열을 가하여 55~65℃, 5시간 동안 추출하였다. 추출액에는 김치에서 유래된 유산균 3종인 락토바실루스 플란타룸(Lactobacillus plantarum), 락토바실루스 에시도필러스(Lactobacillus acidophilus), 페디오코코스 에시디락틱(Pediococcus acidilactici)을 중량1~10%로 접종하여 35~37에서 48시간 배양시킨후, 막걸리에서 분리된 사카로미세스 세레비시아(Saccharomyces cerevisiae) 효모를 접종하여 30~35에서 48시간 2차 배양시킨후 추출액을 이송관을 통해서 이송시키면서 이송관 내에 1mesh에서 100mesh까지 여과하였다. 증발건조기(evaporator)를 이용하여 50브릭스(bx)로 저온 농축한 후 이온교환수지를 채운 칼럼에 흡착시킨 후, 칼럼에 흡착되어 있는 물질을 주정으로 용리하여 정제하여 수지흡착 및 주정용리를 통한 플라티코딘 성분이 5.6배 강화된 추출물을 제조하였고, 제조된 추출물을 감압농축한 후 동결건조하여 건조된 고형물을 파우더로 제조하여 플라티코딘 성분이 강화된 숙성흑도라지 추출물 제조를 완료하였다.The bellflower used in the present invention is obtained by harvesting (about) bellflower cultivated for 5 years or more in Gyeongbuk province, washing the bellflower at 90 ~ 95 ℃ for 2 hours, drying at 50 ~ 60 ℃ for 55 ~ 70 hours, And then dried at 50 to 65 ° C for 55 to 70 hours to prepare aged blackened porridge having a moisture content of 8 to 13%, and then 500% by weight of purified water was added thereto Heat was applied with stirring, and the mixture was extracted at 55 to 65 ° C for 5 hours. Lactobacillus plantarum , Lactobacillus acidophilus , and Pediococcus acidilactici , which are three kinds of lactic acid bacteria derived from kimchi, were inoculated at 1 to 10% After incubation for 48 hours at 37 ° C, Saccharomyces cerevisiae yeast isolated from makkolli was inoculated and cultured at 30-35 for 48 hours. Then, the extract was transferred through a transfer tube, To 100mesh. The mixture was concentrated at low temperature of 50 brix (bx) using an evaporator and adsorbed on a column filled with ion exchange resin. The material adsorbed on the column was purified by eluting with a solvent to obtain a resin The extracts were prepared with 5.6 - fold enhancement of the ticodin component. The resulting extract was concentrated under reduced pressure, and then lyophilized to obtain dried solid, which was powdered to complete the preparation of the aged blackberry extract having enhanced platycin component.

<< 실시예Example 2> 숙성도라지 추출물 및 고순도  2> Agar-bellflower extract and high purity 플라티코딘Platycodine 함유  contain 숙성흑도라지Aging Black Bellflower 추출물의 세포사멸효과 확인 Identification of cell killing effect of extract

<2-1>세포배양<2-1> Cell culture

인간 유래 전립선암 LNCap 세포주를(한국세포주은행, 한국) 열처리 비활성화된 10% 우태아혈정(륜, Fetal Bovine Serum), 100units/ 페니실린(penicillin), 100g/ 스트랩토마이신(streptomycin)을 첨가한 DMEM 배지로 37℃ 및 5% CO2 환경에서 배양하였다.LNCap cell line of human prostate cancer was cultured in DMEM medium supplemented with heat-inactivated 10% fetal bovine serum, 100 units / penicillin, 100 g / streptomycin Lt; RTI ID = 0.0 &gt; 37 C &lt; / RTI &gt; and 5% CO2.

<2-2>농도 의존적 세포 사멸 실험<2-2> Concentration-Dependent Cell Death Experiment

숙성흑도라지 추출물과 고순도 플라티코딘 함유 숙성흑도라지 추출물의 세포사멸 효과를 확인하고자 Cell Counting Kit-8(CCK-8) assay를 실시하였다. 96 웰 플레이트(well plate)에서 LNCap 전립선암 세포주에 시료를 농도별(0, 10, 25, 50, 100 및 200ug/ml)로 처리하고 24시간 동안 배양하였다. CCK-8을 10% 농도로 첨가한 다음 2시간 동안 37에서 반응시킨 후, 마이크로플레이트 스펙트로포토미터(microplate spectrophotometer)(Biorad, Hercules, 미국)를 이용하여 450nm에서 흡광도를 측정하였고, 대조군과의 비교를 통해 상대적인 세포 생존율(%)을 계산하였다.
Cell Counting Kit-8 (CCK-8) assay was performed to determine the cell killing effect of the aged blackberry extract and the high-purity platycodine-containing aged blackberry extract. The samples were treated with LNCap prostate cancer cell lines in 96-well plates at 0, 10, 25, 50, 100 and 200 ug / ml for 24 hours. CCK-8 was added at a concentration of 10%, and reacted at 37 for 2 hours. Absorbance was measured at 450 nm using a microplate spectrophotometer (Biorad, Hercules, USA) and compared with the control group Relative cell viability (%) was calculated.

그 결과 도3에서 보는 바와 같이 숙성흑도라지 추출물과 고순도 플리티코딘함유 숙성흑도라지 추출물은 농도 의존적으로 세포사멸을 유도하는 것을 확인하였다. 대조군을 기준으로 백분율로 환산한 결과 숙성흑도라지 추출물의 경우 25ug/ml 처리군은 92.84%, 50ug/ml 처리군은 88.01%, 100ug/ml처리군은 82.35%, 200ug/ml 처리군은 75.84% 생존율을 나타내었고, 고순도 플라티코딘 함유 숙성흑도라지 추출물의 경우 25ug/ml 처리군은 86.84%, 50ug/ml 처리군은 79.04%, 100ug/ml처리군은 68.38%, 200ug/ml 처리군은 51.03% 생존율을 나타내었다. 고순도 플라티코딘 함유 숙성흑도라지 추출물의 경우 최고 농도에 해당하는 200ug/ml 처리군은 약 50%의 전립선암 세포주 사멸효과를 나타내었다.
As a result, as shown in FIG. 3, it was confirmed that the aged blackberry extract and the high-purity pliticone-containing aged blackberry extract induced cell death in a concentration-dependent manner. As a result, it was found that the treatment of 25 ug / ml, 90 ug / ml treatment group, 82 ug / ml treated group and 75 ㎎% treatment group, respectively, Ml of platycodin containing high-purity platycodine was 86.84%, 79.04% at 25ug / ml, 68.38% at 100ug / ml and 51.03 / % Survival rate. In the case of the high purity platycodin containing aged blackberry extract, the highest concentration of 200 ug / ml treated group showed about 50% of the prostate cancer cell line killing effect.

<2-3>시간 의존적 세포 사멸 실험<2-3> Time-dependent cell death experiments

숙성흑도라지 추출물과 고순도 플라티코딘 함유 숙성흑도라지 추출물의 세포사멸 효과를 확인하고자 Cell Counting Kit-8(CCK-8) assay를 실시하였다. 96 웰 플레이트(well plate)에서 LNCap 전립선암 세포주에 시료를 200ug/ml로 처리하고 24, 48, 72시간동안 배양 하였다. CCK-8을 10% 농도로 첨가한 다음 2시간동안 37에서 반응시킨 후, 마이크로플레이트 스펙트로포토미터(microplate spectrophotometer)(Biorad, Hercules, 미국)를 이용하여 450nm에서 흡광도를 측정하고, 대조군과의 비교를 통해 상대적인 세포 생존율(%)을 계산하였다.
Cell Counting Kit-8 (CCK-8) assay was performed to determine the cell killing effect of the aged blackberry extract and the high-purity platycodine-containing aged blackberry extract. LNCap prostate cancer cell line was treated with 200 ug / ml of the sample in a 96 well plate and cultured for 24, 48, 72 hours. CCK-8 was added at a concentration of 10% and reacted at 37 for 2 hours. Absorbance was measured at 450 nm using a microplate spectrophotometer (Biorad, Hercules, USA) and compared with the control group Relative cell viability (%) was calculated.

그 결과 도 4에서 보는 바와 같이 숙성흑도라지 추출물과 고순도 플라티코딘 함유 숙성흑도라지추출물은 시간 의존적으로 세포사멸을 유도하는 것을 확인하였다. 대조군을 기준으로 백분율로 환산한 결과 숙성흑도라지 추출물은 24시간 처리군에서 80.2%, 48시간 처리군은 71.16%, 72시간 처리군은 67.33% 생존율을 나타내었고 고플라티코딘 함유 숙성흑도라지 추출물은 24시간 처리군에서 64.04%, 48시간 처리군은 51.49%, 72시간 처리군은 44.59% 생존율을 나타냄으로써 시간 의존적인 전립선암 세포주 사멸 효과를 확인하였으며, 특히 고순도 플라티코딘이 함유된 숙성흑도라지 추출물의 경우 동일한 농도조건에서 전립선암 세포주 사멸 효과는 약 1.5배 높은 것으로 나타나 플라티코딘이 고용량 함유된 추출물에서 효과가 뛰어난 것을 알 수 있다.
As a result, as shown in FIG. 4, it was confirmed that the aged blackberry extract and the high-purity platycodine-containing aged blackberry extract induce apoptosis in a time-dependent manner. As a result, the survival rate of the fermented black platycodon extracts was 80.2%, 71.16% and 72.33% in 24 hours, 72 hours and 67.33%, respectively. The survival rate was 64.04% in the 24 hours treatment group, 51.49% in the 48 hours treatment group and 44.59% in the 72 hours treatment group, confirming the time-dependent effect of prostate cancer cell line killing, In the case of Platycodon grandiflorum extract, the effect of prostate cancer cell line killing was found to be about 1.5 times higher under the same concentration conditions.

<< 실시예Example 3>  3> caspasecaspase -3 발현 평가 실험-3 expression evaluation experiment

LNCap 전립선암 세포주에 고순도 플라티코딘 함유 숙성흑도라지 추출물 시료를 농도별(0, 10, 25, 50, 100 및 200ug/ml)로 처리하고 24시간 동안 배양하였다. Caspase-3 발현 평가를 위해 세포는 회수하여 lysis 버퍼(50mM Tris-HCl, pH7.4, 150mM Nacl, 0.1% SDS, 1.0% Triton X-100, 0.25% Deoxycholate, 1mM EDTA, 1mM PMSF)를 가하여 파쇄하였다. 세포를 용해하여 획득한 균질액을 12000rpm 15분 동안 원심분리하여 단백질 층을 얻었으며, 웨스턴 블록(western blot) 방법을 이용하여 Caspase-3 단백질의 발현정도를 측정하였다. 50g의 단백질은 SDS-polyacrylamide gel에 주입하여 전기영동한 후 nitrocellulose membrane에 transfer 하였다. Membrane을 blocking solution(5% skim milk, 10mM Tris, pH7.5, 10mM NaCl, 0.1% Tween 20)에 1시간 반응시켜 nonspecific blinding을 배제한 후 Caspase-3 단백질의 primary antibody를 넣고 상온에서 2시간 반응시켰다. Blocking solution을 이용하여 10분간 3번 씻어준후 secondary antibody를 넣고 1시간 반응시키고 위와 같은 방법으로 세척하였다. ECL 용액을 가한 membrane을 X-ray film에 노출시킨 후 단백질 변화량을 확인하였다. 변화량은 image analyzer를 이용하여 광학밀도(optical density)로 산출하였다.
LNCap prostate cancer cell lines were treated with high purity platycodin-containing aged blackberry extracts at concentrations of 0, 10, 25, 50, 100 and 200 ug / ml and cultured for 24 hours. Cells were collected and lysed by adding lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM Nacl, 0.1% SDS, 1.0% Triton X-100, 0.25% Deoxycholate, 1 mM EDTA, 1 mM PMSF) Respectively. Cells were lysed and the obtained homogenate was centrifuged at 12,000 rpm for 15 minutes to obtain a protein layer. The expression level of Caspase-3 protein was measured using a western blot method. 50 g of protein was electrophoresed on SDS-polyacrylamide gel and transferred to nitrocellulose membrane. Membrane was reacted with blocking solution (5% skim milk, 10 mM Tris, pH 7.5, 10 mM NaCl, 0.1% Tween 20) for 1 hour to exclude nonspecific blinding. Primary antibody of Caspase-3 protein was added and reacted at room temperature for 2 hours . After washing 3 times for 10 minutes with blocking solution, secondary antibody was added and reacted for 1 hour and washed as above. After the ECL solution was exposed to X-ray film, the amount of protein change was confirmed. The amount of change was calculated by optical density using an image analyzer.

도 4에서 보는 바와 같이, caspase-3 단백질 발현 수준을 관찰한 결과 활성화를 살펴본 결과, 고순도 플라티코딘 함유 숙성흑도라지 추출물을 농도별로 처리함으로써 caspase-3 발현이 농도 의존적으로 증가하는 것으로 나타났다. 이는 숙성흑도라지가 세포자기사멸의 주요 단백질 발현 증가를 통한 세포자기사멸을 증가시킨 것을 의미한다.
As shown in FIG. 4, when caspase-3 protein expression levels were examined, the expression of caspase-3 was increased in a concentration-dependent manner by treating the high-purity platocidin-containing aged blackberry extract with concentration. This means that aged blackrod grains increased cell death by increasing the expression of major proteins of cell apoptosis.

Claims (5)

a) 5년근 약도라지를 90~95℃에서 2시간 증자 후 50~60℃에서 55~70시간 건조하는 단계;
b) 건조한 도라지를 정제수로 추출하는 단계;
c) 추출액에 3종 유산균 락토바실루스 플란타룸(Lactobacillus plantarum), 락토바실루스 에시도필러스(Lactobacillus acidophilus), 페디오코코스 에시디락틱(Pediococcus acidilactici)으로 배양시키는 단계;
d) 3종 유산균으로 배양 후 1종의 효모 사카로미세스 세레비시아(Saccharomyces cerevisiae)로 배양시키는 단계:
e) 배양된 추출액을 여과 및 농축시키는 단계; 및
f) 상기 e)단계의 농축물을 이온교환수지에 흡착한 후 주정 함유 수용액을 용출용매로 고순도의 플라티코딘A, D을 함유하는 농축물을 정제하는 단계에 의하여 얻은 것임을 특징으로 하는 전립선암 예방에 우수한 숙성흑도라지 추출물








a) 5-year old Rhododendron at 90 ~ 95 ° C for 2 hours and drying at 50 ~ 60 ° C for 55 ~ 70 hours;
b) extracting the dried bellflower with purified water;
c) culturing the extract in a Lactobacillus plantarum , a Lactobacillus acidophilus , or a Pediococcus acidilactici with three kinds of lactic acid bacteria, Lactobacillus plantarum , Lactobacillus acidophilus and Pediococcus acidilactici ;
d) Culturing with three kinds of lactic acid bacteria and culturing with one kind of Saccharomyces cerevisiae :
e) filtering and concentrating the cultured extract; And
f) adsorbing the concentrate of step e) on an ion exchange resin, and then purifying the concentrate containing high purity platycodin A, D as an eluting solvent in an aqueous solution containing the alcohol. Excellent aging for prevention Black rosewood extract








삭제delete 삭제delete 삭제delete 삭제delete
KR1020160176600A 2016-12-22 2016-12-22 The preventing prostate cancer composition containing high platycodin aged Doraji extract methods KR101923781B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160176600A KR101923781B1 (en) 2016-12-22 2016-12-22 The preventing prostate cancer composition containing high platycodin aged Doraji extract methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160176600A KR101923781B1 (en) 2016-12-22 2016-12-22 The preventing prostate cancer composition containing high platycodin aged Doraji extract methods

Publications (2)

Publication Number Publication Date
KR20180073109A KR20180073109A (en) 2018-07-02
KR101923781B1 true KR101923781B1 (en) 2018-11-29

Family

ID=62914396

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160176600A KR101923781B1 (en) 2016-12-22 2016-12-22 The preventing prostate cancer composition containing high platycodin aged Doraji extract methods

Country Status (1)

Country Link
KR (1) KR101923781B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102294544B1 (en) * 2019-05-07 2021-08-27 대한민국 Pharmaceutical composition for preventing and treating prostate disease, comprising the compound isolated from Platycodon grandiflorum and Platycodon grandiflorum extract as an active ingredient

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101352373B1 (en) * 2012-03-16 2014-01-22 허니플 영농조합법인 Black doraji extract and its manufacturing method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101352373B1 (en) * 2012-03-16 2014-01-22 허니플 영농조합법인 Black doraji extract and its manufacturing method

Also Published As

Publication number Publication date
KR20180073109A (en) 2018-07-02

Similar Documents

Publication Publication Date Title
CN107929339B (en) Preparation method of black ginseng
KR101339706B1 (en) A compound for immune strengthen inclusion reducing the bitterness of red ginseng, the extract of immune, and the probiotics
KR20170061959A (en) Preparation method of fermented ginseng and fermented black-red ginseng with active ginsenoside heightening rate absorption
US20190142046A1 (en) Functionally reinforced desalted nutritional compositions from halophytes and preparation method thereof
KR101681810B1 (en) Ginseng preparations containing abundant ginsenoside using a beauveria bassiana and method thereof
CN103301321B (en) Thrombolytic active polysaccharide mixture preparation technology
KR101923781B1 (en) The preventing prostate cancer composition containing high platycodin aged Doraji extract methods
US11622983B2 (en) Pharmaceutical composition for preventing or treating neurodegenerative diseases including fermented steam-dried ginseng berry
KR101816821B1 (en) Functioanl tea with anticancer activity and manufacturing method thefeof
KR20160126591A (en) Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same
KR102115622B1 (en) Pharmaceutical composition comprising the fermentation extract of medicinal or edible natural products as an effective component for prevention or treatment of thrombosis and health functional food comprising the same
KR20180057754A (en) Composition comprising fermented extracts having anti-atopic activity
CN104887780A (en) Preparation method of active dark plum extract and application in inhibition of helicobacter pylori
KR20130005869A (en) Red ginseng liquid using two step fermentation of lactic acid bacteria
KR20180003002A (en) A pharmaceutical composition for preventing or treating inflammation comprising Inonotus obliquus extract as an active ingredient
KR20120019311A (en) Composition for immunostimulation which comprises polysaccharide from fermented ginseng with phellinus linteus to enhance the immune function
CN105255685A (en) Lucid ganoderma and tabasheer wine
KR101131719B1 (en) Pulsatilla koreana extracts compositions for treating or preventing inflammatory diseases
KR101097664B1 (en) Method of processing roots of korea ginseng
KR20160148936A (en) a novel compound (KS 513) isolated from the extract of Pseudolysimachion rotundum var. subintegrum and the composition comprising the same as an active ingredient for preventing or treating allergy disease, inflammatory disease, asthma or chronic obstructive pulmonary disease
KR20160077285A (en) Method for producing fermented red ginseng with enhanced ginsenoside Rg3 content
JPS61194032A (en) Pulverized coriolus versicolor containing large amount of ganoderic acid as useful component, and production thereof
KR20200131555A (en) Composition for health functional beverage and manufacturing method thereof
CN115025017B (en) Ligusticum wallichii and cimicifuga foetida mixed enzymolysis liquid and application thereof
CN108185435A (en) A kind of Sang Ju Yin bacterium product and preparation method and application

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right